Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-03-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0014-2999(99)00006-0PMID 10193651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tolerance to the anti-pentylenetetrazole effects of diazepam in the mouse

  2004cited by this paper
• Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.

  1998cited by this paper
• Antiepileptogenic and Anticonvulsant Effects of YM90K, a Selective AMPA‐Receptor Antagonist, in the Rat Kindling Model of Epilepsy

  1998cited by this paper
• Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats.

  1998cited by this paper
• 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

  1997cited by this paper
• Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.

  1996cited by this paper
• Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.

  1996cited by this paper
• Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CFP 37849 and CGP 39551 in genetically epilepsy-prone rats

  1996cited by this paper
• Kainate/AMPA receptor antagonists are anticonvulsant against the tonic hindlimb component of pentylenetetrazol-induced seizures in developing rats.

  1995cited by this paper
• Exitatory Amino Acids in Health and Disease

  1995cited by this paper
• GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.

  1995cited by this paper
• Glutamate, GABA and epilepsy.

  1995cited by this paper
• Effects of the non‐NMDA antagonists NBQX and the 2,3‐benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil

  1994cited by this paper
• The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.

  1994cited by this paper
• Cellular and molecular basis of epilepsy

  1994cited by this paper
• The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.

  1994cited by this paper
• Kindling induces the long-lasting expression of a novel population of NMDA receptors in hippocampal region CA3

  1994cited by this paper
• Over-additive anticonvulsant effect of memantine and NBQX in kindled rats.

  1994cited by this paper
• Over-additive anticonvulsant effect of memantine and NBQX in kindled rats

  1994cited by this paper
• Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

  1994cited by this paper
• Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.

  1993cited by this paper
• Acute and chronic anticonvulsant effects of D(-)CPPene in genetically epilepsy-prone rats.

  1993cited by this paper
• Anticonvulsant Action of Oxcarbazepine, Hydroxycarbamazepine, and Carbamazepine Against Metrazol‐Induced Motor Seizures in Developing Rats

  1993cited by this paper
• Low Doses of NMDA Receptor Antagonists Synergistically Increase the Anticonvulsant Effect of the AMPA Receptor Antagonist NBQX in the Kindling Model of Epilepsy

  1993cited by this paper
• Roles of the NMDA and quisqualate/kainate receptors in the induction and expression of kindled bursts in rat hippocampal slices.

  1993cited by this paper
• Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

  1993cited by this paper
• Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.

  1993cited by this paper
• A synaptic model of memory: long-term potentiation in the hippocampus

  1993cited by this paper
• Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.

  1992cited by this paper
• The Clinical Relevance of Kindling

  1992cited by this paper
• Tolerance to anticonvulsant effects of clobazam, diazepam, and clonazepam in genetically epilepsy prone rats.

  1992cited by this paper
• Rational basis for the development of new antiepileptic drugs.

  1991cited by this paper
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.

  1991cited by this paper
• The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.

  1991cited by this paper
• An Important Role of Non‐NMDA Receptors in the Expression of Kindled Amygdaloid Seizure in Rats

  1991cited by this paper
• Kindling: basic mechanisms and clinical validity.

  1990cited by this paper
• The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures.

  1990cited by this paper
• The role of NMDA receptors in epilepsy: I. Effects of NMDA receptor antagonists (CPP and MK-801) on amygdala kindling in rats.

  1990cited by this paper
• Anticonvulsant properties of some calcium antagonists on sound-induced seizures in genetically epilepsy prone rats.

  1990cited by this paper
• Development of New Pharmacological Agents for Epilepsy: Lessons from the Kindling Model

  1989cited by this paper
• Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466.

  1989cited by this paper
• Regulation of seizure threshold by excitatory amino acids in the striatum and entopeduncular nucleus of rats.

  1988cited by this paper
• Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.

  1988cited by this paper
• Contributions of quisqualate and NMDA receptors to the induction and expression of LTP.

  1988cited by this paper
• Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists.

  1988cited by this paper
• Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.

  1988cited by this paper
• Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

  1988cited by this paper
• Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling.

  1988cited by this paper
• Anticonvulsant action of a kainate antagonist gamma-D-glutamyl aminomethylsulphonic acid injected focally into the substantia nigra and entopeduncular nucleus.

  1986cited by this paper
• Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

  1986cited by this paper
• Tolerance to beneficial and adverse effects of antiepileptic drugs

  1986cited by this paper
• Pharmacology of hearing : Edited by R. D. Brown and E. A. Daigneault. John Wiley, New York, 1981, 353 pp. Price not given.

  1982cited by this paper
• PCP (phencyclidine), historical and current perspectives

  1981cited by this paper
• Antiepileptic Properties of Clobazam, a 1–5 Benzodiazepine, in Man

  1979cited by this paper
• Additional studies on the importance of glycine and GABA in mediating the actions of benzodiazepines.

  1977cited by this paper
• Development of tolerance to and physical dependence on barbiturates in rhesus monkeys.

  1970cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• Tolerance to some effects of barbiturates.

  1957cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats.

  2022cites this paper
• Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats.

  2018cites this paper
• Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs.

  2017cites this paper
• Combined Blockade of AMPA and NMDA Receptors Produces Maximal Suppression of the Development of Corasol Kindling in Rats

  2015cites this paper
• Docking and Synthesis of 2-Arylisoindoline-1,3-dione Derivatives as Anticonvulsant Agents

  2014cites this paper
• Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy

  2014cites this paper
• Effects of transcranial focal electrical stimulation via tripolar concentric ring electrodes on pentylenetetrazole-induced seizures in rats.

  2013cites this paper
• Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders

  2012cites this paper
• Characterization of Seizures Induced by Acute and Repeated Exposure to Tetramethylenedisulfotetramine

  2012cites this paper
• AMPA Receptor-Induced Local Brain-Derived Neurotrophic Factor Signaling Mediates Motor Recovery after Stroke

  2011influential citation
• AMPAReceptor-InducedLocalBrain-DerivedNeurotrophic FactorSignalingMediatesMotorRecoveryafterStroke

  2011cites this paper
• Acute Seizure Tests in Epilepsy Research: Electroshock‐ and Chemical‐Induced Convulsions in the Mouse

  2009cites this paper
• Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase.

  2009cites this paper
• Author ' s personal copy PARADOXICAL FACILITATION OF PENTYLENETETRAZOLE-INDUCED CONVULSION SUSCEPTIBILITY IN MICE LACKING NEURONAL NITRIC OXIDE SYNTHASE

  2009cites this paper
• Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy.

  2008cites this paper
• CHAPTER 31 – Chemical Kindling

  2006cites this paper
• Genetically Epilepsy‐Prone Rats (GEPRs) in Drug Research

  2006cites this paper
• Investigation of the mechanisms of action of the anticonvulsant topiramate : electrophysiological studies on rat olfactory cortical neurones in vitro and some in vivo rodent models of epilepsy.

  2005cites this paper
• AMPA receptor antagonists as potential anticonvulsant drugs.

  2005cites this paper
• Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents.

  2004cites this paper
• Studies of the Roles of NMDA and AMPA Glutamate Receptors in the Mechanism of Corasole Convulsions in Mice

  2004cites this paper
• Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.

  2004cites this paper
• Spinal neurotoxicity and tolerance after repeated intrathecal administration of YM 872, an AMPA receptor antagonist, in rats

  2004cites this paper
• Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents.

  2003cites this paper
• Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice.

  2002cites this paper
• Inhibitors of AMPA and kainate receptors.

  2001cites this paper
• AMPA Receptors: potential implications in development and disease

  2001cites this paper
• Models of Epilepsy: Electroshock and Chemical Induced Convulsions in the Mouse

  2000cites this paper